학술논문


EBSCO Discovery Service
발행년
-
(예 : 2010-2015)
전자자료 공정이용 안내

우리 대학 도서관에서 구독·제공하는 모든 전자자료(데이터베이스, 전자저널, 전자책 등)는 국내외 저작권법과 출판사와의 라이선스 계약에 따라 엄격하게 보호를 받고 있습니다.
전자자료의 비정상적 이용은 출판사로부터의 경고, 서비스 차단, 손해배상 청구 등 학교 전체에 심각한 불이익을 초래할 수 있으므로, 아래의 공정이용 지침을 반드시 준수해 주시기 바랍니다.

공정이용 지침
  • 전자자료는 개인의 학습·교육·연구 목적의 비영리적 사용에 한하여 이용할 수 있습니다.
  • 합리적인 수준의 다운로드 및 출력만 허용됩니다. (일반적으로 동일 PC에서 동일 출판사의 논문을 1일 30건 이하 다운로드할 것을 권장하며, 출판사별 기준에 따라 다를 수 있습니다.)
  • 출판사에서 제공한 논문의 URL을 수업 관련 웹사이트에 게재할 수 있으나, 출판사 원문 파일 자체를 복제·배포해서는 안 됩니다.
  • 본인의 ID/PW를 타인에게 제공하지 말고, 도용되지 않도록 철저히 관리해 주시기 바랍니다.
불공정 이용 사례
  • 전자적·기계적 수단(다운로딩 프로그램, 웹 크롤러, 로봇, 매크로, RPA 등)을 이용한 대량 다운로드
  • 동일 컴퓨터 또는 동일 IP에서 단시간 내 다수의 원문을 집중적으로 다운로드하거나, 전권(whole issue) 다운로드
  • 저장·출력한 자료를 타인에게 배포하거나 개인 블로그·웹하드 등에 업로드
  • 상업적·영리적 목적으로 자료를 전송·복제·활용
  • ID/PW를 타인에게 양도하거나 타인 계정을 도용하여 이용
  • EndNote, Mendeley 등 서지관리 프로그램의 Find Full Text 기능을 이용한 대량 다운로드
  • 출판사 콘텐츠를 생성형 AI 시스템에서 활용하는 행위(업로드, 개발, 학습, 프로그래밍, 개선 또는 강화 등)
위반 시 제재
  • 출판사에 의한 해당 IP 또는 기관 전체 접속 차단
  • 출판사 배상 요구 시 위반자 개인이 배상 책임 부담
'학술논문' 에서 검색결과 376건 | 목록 1~20
Academic Journal
Опухоли женской репродуктивной системы, Vol 21, Iss 1, Pp 123-131 (2025)
Academic Journal
Yongue G; University College London Cancer Institute, London, UK.; University College London Hospital, London, UK.; Nash Z; University College London Hospital, London, UK.; EGA Institute for Women's Health, London, UK.; Talaulikar V; University College London Hospital, London, UK.; EGA Institute for Women's Health, London, UK.; Nicum S; University College London Cancer Institute, London, UK.; University College London Hospital, London, UK.
Publisher: Wiley-Blackwell Country of Publication: England NLM ID: 100935741 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1471-0528 (Electronic) Linking ISSN: 14700328 NLM ISO Abbreviation: BJOG Subsets: MEDLINE
Academic Journal
Merry E; Medical Oncology, University College London Hospitals NHS Foundation Trust, London, UK. Electronic address: Eve.Merry@nhs.net.; Kesmez RT; Bart's Cancer Institute, Queen Mary University of London, London, UK.; Yu T; Medical Oncology, University College London Hospitals NHS Foundation Trust, London, UK.; Flynn M; Medical Oncology, University College London Hospitals NHS Foundation Trust, London, UK.; Ledermann J; Medical Oncology, University College London Hospitals NHS Foundation Trust, London, UK; UCL Cancer Institute, London, UK.; Lockley M; Medical Oncology, University College London Hospitals NHS Foundation Trust, London, UK; Bart's Cancer Institute, Queen Mary University of London, London, UK.; Macdonald N; Gynaecological Oncology, University College London Hospitals NHS Foundation Trust, London, UK.; McCormack M; Oncology, University College London Hospitals NHS Foundation Trust, London, UK.; Nicum S; Medical Oncology, University College London Hospitals NHS Foundation Trust, London, UK.; Crusz S; Medical Oncology, Barts Health NHS Trust, London, UK.; Miller R; Medical Oncology, University College London Hospitals NHS Foundation Trust, London, UK; Medical Oncology, Barts Health NHS Trust, London, UK.
Publisher: Elsevier Country of Publication: United States NLM ID: 9111626 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1525-1438 (Electronic) Linking ISSN: 1048891X NLM ISO Abbreviation: Int J Gynecol Cancer Subsets: MEDLINE
Academic Journal
Steventon L; Medical Oncology Department and Centre of Medicines Optimization Research and Education (CMORE), University College Hospitals NHS Foundation Trust, 235 Euston rd, London NW1 2PP, United Kingdom.; Department of Practice and Policy, UCL School of Pharmacy, London WC1H 9JP, United Kingdom.; Man KKC; Medical Oncology Department and Centre of Medicines Optimization Research and Education (CMORE), University College Hospitals NHS Foundation Trust, 235 Euston rd, London NW1 2PP, United Kingdom.; Department of Practice and Policy, UCL School of Pharmacy, London WC1H 9JP, United Kingdom.; Nicum S; Medical Oncology Department and Centre of Medicines Optimization Research and Education (CMORE), University College Hospitals NHS Foundation Trust, 235 Euston rd, London NW1 2PP, United Kingdom.; UCL Cancer Institute, Department of Oncology, London WC1 6DD, United Kingdom.; Miller RE; Medical Oncology Department and Centre of Medicines Optimization Research and Education (CMORE), University College Hospitals NHS Foundation Trust, 235 Euston rd, London NW1 2PP, United Kingdom.; Peleg Hasson S; School of Medicine, Tel Aviv University, Tel Aviv, Israel.; The Royal Marsden NHS Trust, London SW3 6JJ, United Kingdom.; Shah S; Medical Oncology Department and Centre of Medicines Optimization Research and Education (CMORE), University College Hospitals NHS Foundation Trust, 235 Euston rd, London NW1 2PP, United Kingdom.; Baser M; National Disease Registration Service (NDRS), NHS England, London E14 4PU, United Kingdom.; Kipps E; The Royal Marsden NHS Trust, London SW3 6JJ, United Kingdom.; Forster MD; Medical Oncology Department and Centre of Medicines Optimization Research and Education (CMORE), University College Hospitals NHS Foundation Trust, 235 Euston rd, London NW1 2PP, United Kingdom.; UCL Cancer Institute, Department of Oncology, London WC1 6DD, United Kingdom.; Almossawi O; Great Ormond Street Hospital for Children NHS Foundation Trust, Population, Policy & Practice Department, London WC1N 1LE, United Kingdom.; Chambers P; Medical Oncology Department and Centre of Medicines Optimization Research and Education (CMORE), University College Hospitals NHS Foundation Trust, 235 Euston rd, London NW1 2PP, United Kingdom.; Department of Practice and Policy, UCL School of Pharmacy, London WC1H 9JP, United Kingdom.
Publisher: Oxford University Press Country of Publication: England NLM ID: 9607837 Publication Model: Print Cited Medium: Internet ISSN: 1549-490X (Electronic) Linking ISSN: 10837159 NLM ISO Abbreviation: Oncologist Subsets: MEDLINE
Academic Journal
Br J Cancer
Roberts, C, Strauss, V Y, Kopijasz, S, Gourley, C, Hall, M, Montes, A, Abraham, J, Clamp, A, Kennedy, R, Banerjee, S, Folkes, L K, Stratford, M & Nicum, S 2020, 'Results of a phase II clinical trial of 6-mercaptopurine (6MP) and methotrexate in patients with BRCA-defective tumours', British Journal of Cancer, vol. 122, no. 4, pp. 483-490. https://doi.org/10.1038/s41416-019-0674-4
Roberts, C, Strauss, V Y, Kopijasz, S, Gourley, C, Hall, M, Montes, A, Abraham, J, Clamp, A, Kennedy, R, Banerjee, S, Folkes, L K, Stratford, M & Nicum, S 2020, ' Results of a phase II clinical trial of 6-mercaptopurine (6MP) and methotrexate in patients with BRCA-defective tumours ', British Journal of Cancer, vol. 122, no. 4, pp. 483-490 . https://doi.org/10.1038/s41416-019-0674-4, https://doi.org/10.1038/s41416-019-0674-4
Academic Journal
Olawaiye AB; University of Pittsburgh School of Medicine and UPMC Magee-Women's Hospital, Gynecologic Oncology Group, Pittsburgh, PA, USA. Electronic address: olawaiyea@upmc.edu.; Gladieff L; Oncopole Claudius Regaud IUCT-Oncopole, Toulouse, France; GINECO, Paris, France.; O'Malley DM; James Comprehensive Cancer Center, The Ohio State University, Columbus, OH, USA.; Kim JW; Department of Obstetrics and Gynecology, Seoul National University College of Medicine, Seoul, South Korea.; Garbaos G; Instituto Médico de la Fundación Estudios Clínicos, Santa Fe, Argentina.; Salutari V; Department of Woman, Child, and Public Health, Fondazione Policlinico Universitario Agostino Gemelli, Rome, Italy.; Gilbert L; Division of Gynecologic Oncology, Research Institute, McGill University Health Centre, Gerald Bronfman Department of Oncology, McGill University, Montreal, QC, Canada.; Mileshkin L; Department of Medical Oncology, Peter MacCallum Cancer Centre, Melbourne, VIC, Australia.; Devaux A; Oncology Department of Grand Hôpital de Charleroi, Charleroi, Belgium; Belgium and Luxembourg Gynaecological Oncology Group, Leuven, Belgium.; Hopp E; Department of Obstetrics and Gynecology, Medical College of Wisconsin, Milwaukee, WI, USA.; Lee YJ; Yonsei University College of Medicine, Seoul, South Korea.; Oaknin A; Medical Oncology Service, Vall d'Hebron Institute of Oncology, Vall d'Hebron Barcelona Hospital Campus, Barcelona, Spain.; Scaranti M; DASA Oncologia, Hospital 9 de Julho, São Paulo, Brazil.; Kim BG; Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, South Korea.; Colombo N; Gynecologic Oncology Program, European Institute of Oncology, IRCCS, Milan, Italy; Department of Medicine and Surgery, University of Milan-Bicocca, Milan, Italy.; McCollum ME; Virginia Oncology Associates, Norfolk, VA, USA.; Diakos C; Royal North Shore Hospital, St Leonards, NSW, Australia.; Clamp A; The Christie NHS Foundation Trust, Manchester, UK; University of Manchester, Manchester, UK.; Leiser AL; Rutgers Cancer Institute of New Jersey, New Brunswick, NJ, USA.; Balázs B; Department of Gynecology, Hungarian National Institute of Oncology, Budapest, Hungary.; Monk BJ; Florida Cancer Specialists and Research Institute, West Palm Beach, FL, USA.; Scandurra G; Medical Oncology Unit, Cannizzaro Hospital, Catania, Italy; Faculty of Medicine, Kore University of Enna, Enna, Italy.; McClung E; Stanford University, Palo Alto, CA, USA.; Kaczmarek E; Centre Oscar Lambret, Lille, France; GINECO, Paris, France.; Slomovitz B; Mount Sinai Comprehensive Cancer Center, Miami Beach, FL, USA.; De La Cueva H; Hospital La Fe Valencia, Valencia, Spain.; de Carvalho Calabrich AF; Ensino e Terapia de Inovação Clínica AMO-ETICA, Salvador, Brazil.; Cassani C; Department of Clinical, Surgical, Diagnostic, and Pediatric Sciences, University of Pavia, Pavia, Italy; Unit of Obstetrics and Gynecology, IRCCS San Matteo Foundation, Pavia, Italy.; You B; GINECO, Paris, France; Lyon University Hospital (HCL), Lyon, France.; Van Gorp T; University Hospital Leuven, Leuven Cancer Institute, Leuven, Belgium; Belgium and Luxembourg Gynaecological Oncology Group, Leuven, Belgium.; Churruca C; Hospital Donostia, San Sebastián, Spain.; Caruso G; Gynecologic Oncology Program, European Institute of Oncology, IRCCS, Milan, Italy; Department of Experimental Medicine, Sapienza University of Rome, Rome, Italy.; Nicum S; University College Hospital, London, UK.; Bagaméri A; Department of Gynecology, Hungarian National Institute of Oncology, Budapest, Hungary.; Artioli G; Azienda ULSS2 Marca Trevigiana, Treviso, Italy.; Bodnar L; Institute of Health Sciences, University of Siedlce, Siedlce, Poland.; Kang S; Department of Cancer Control and Population Health, National Cancer Center, Goyang, South Korea.; Vergote I; Department of Gynecologic Oncology, University Hospital Leuven, Leuven, Belgium.; Kesner-Hays A; Corcept Therapeutics, Redwood City, CA, USA.; Pashova HI; Corcept Therapeutics, Redwood City, CA, USA.; Pai SG; Corcept Therapeutics, Redwood City, CA, USA.; Tudor IC; Corcept Therapeutics, Redwood City, CA, USA.; Jubb AM; Corcept Therapeutics, Redwood City, CA, USA.; Lorusso D; Department of Biomedical Science, Humanitas University, Pieve Emanuele, Italy; Humanitas San Pio X Hospital, Milan, Italy.
Publisher: Elsevier Country of Publication: England NLM ID: 2985213R Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1474-547X (Electronic) Linking ISSN: 01406736 NLM ISO Abbreviation: Lancet Subsets: MEDLINE
Academic Journal
Taylor A; Department of Gynaecology Oncology, The Royal Marsden Hospital NHS Trust, London, UK.; The Institute of Cancer Research, London, UK.; Clement K; Department of Gynaecology, Newcastle Upon Tyne Hospitals NHS Foundation Trust, Newcastle Upon Tyne, UK.; Hillard T; Department of Gynaecology, University Hospitals Dorset NHS Foundation Trust, Poole, UK.; Sassarini J; Department of Obstetrics and Gynaecology, NHS Greater Glasgow and Clyde, Glasgow, UK.; Ratnavelu N; Northern Gynaecological Oncology Centre, Gateshead Health NHS Foundation Trust, Gateshead, UK.; Baker-Rand H; Department of Gynaecological Oncology, Grace Centre, Musgrove Park Hospital, Taunton, UK.; Bowen R; Department of Oncology, Royal United Hospitals Bath NHS Foundation Trust, Bath, UK.; University of Bath, Bath, UK.; Davies MC; Reproductive Medicine Unit, University College London Hospitals NHS Foundation Trust, London, UK.; Edey K; Department of Gynaecological Oncology, Royal Devon University NHS Foundation Trust, Exeter, UK.; Fernandes A; Department of Gynaecology Oncology, The Royal Marsden Hospital NHS Trust, London, UK.; Ghaem-Maghami S; Department of Surgery and Cancer, Imperial College, London University, London, UK.; Gomes N; Department of Gynaecology Oncology, The Royal Marsden Hospital NHS Trust, London, UK.; Gray S; St Erme Medical, Truro, UK.; Hughes E; Jo's Trust Charity, London, UK.; Hudson A; Ovacome Ovarian Cancer Charity, London, UK.; Manchanda R; Wolfson Institute of Population Health, Queen Mary University of London, London, UK.; Department of Gynaecological Oncology, Barts Health NHS Trust, London, UK.; Manley K; Department of Gynaecology, University Hospitals Bristol NHS Foundation Trust, Bristol, UK.; Nicum S; Department of Medical Oncology, University College Hospital, London, UK.; University College London, London, UK.; Phillips A; Derby Gynaecological Cancer Centre, University Hospitals of Derby and Burton NHS Foundation Trust, Derby, UK.; Richardson A; Derby Gynaecological Cancer Centre, University Hospitals of Derby and Burton NHS Foundation Trust, Derby, UK.; Morrison J; Department of Gynaecological Oncology, Grace Centre, Musgrove Park Hospital, Taunton, UK.; Faculty of Health and Life Sciences, University of Exeter, Exeter, UK.
Publisher: Sage Country of Publication: United States NLM ID: 101626590 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 2053-3705 (Electronic) Linking ISSN: 20533691 NLM ISO Abbreviation: Post Reprod Health Subsets: MEDLINE
Academic Journal
JCI Insight
JCI Insight, Vol 6, Iss 11 (2021)
Artibani, M, Masuda, K, Hu, Z, Rauher, P C, Mallett, G, Wietek, N, Morotti, M, Chong, K, Ranjbar, M K N, Zois, C E, Dhar, S, El-Sahhar, S, Campo, L, Blagden, S P, Damato, S, Pathiraja, P N, Nicum, S, Gleeson, F, Laios, A, Alsaadi, A, Gonzalez, L S, Motohara, T, Albukhari, A, Lu, Z, Bast, R C, Harris, A L, Ejsing, C S, Klemm, R W, Yau, C, Sauka-Spengler, T & Ahmed, A A 2021, ' Adipocyte-like signature in ovarian cancer minimal residual disease identifies metabolic vulnerabilities of tumorinitiating cells ', JCI Insight, vol. 6, no. 11, e147929 . https://doi.org/10.1172/jci.insight.147929
Academic Journal
Steventon L; Research Department of Practice and Policy, Mezzanine Floor, BMA House, Tavistock Square, UCL School of Pharmacy, London, WC1H 9JP, United Kingdom; University College London Hospital NHS Foundation Trust, 235 Euston Road, London, NW1 2BU, United Kingdom.; Nicum S; University College London Hospital NHS Foundation Trust, 235 Euston Road, London, NW1 2BU, United Kingdom.; Chambers P; Research Department of Practice and Policy, Mezzanine Floor, BMA House, Tavistock Square, UCL School of Pharmacy, London, WC1H 9JP, United Kingdom; University College London Hospital NHS Foundation Trust, 235 Euston Road, London, NW1 2BU, United Kingdom.; Man K; Research Department of Practice and Policy, Mezzanine Floor, BMA House, Tavistock Square, UCL School of Pharmacy, London, WC1H 9JP, United Kingdom.; Dodwell D; Nuffield Department of Population Health, Roosevelt Drive, Headington, University of Oxford, Oxford, OX3 7LH, United Kingdom.; Wang Z; Nuffield Department of Population Health, Roosevelt Drive, Headington, University of Oxford, Oxford, OX3 7LH, United Kingdom.; Patel A; University College London Hospital NHS Foundation Trust, 235 Euston Road, London, NW1 2BU, United Kingdom.; Pickwell-Smith B; Leeds Teaching Hospitals NHS Trust, Beckett Street, Leeds, LS9 7TF, United Kingdom; Medical Oncology Department, University of Leeds, Leeds, LS9 7LP, United Kingdom.; Wei L; Research Department of Practice and Policy, Mezzanine Floor, BMA House, Tavistock Square, UCL School of Pharmacy, London, WC1H 9JP, United Kingdom. Electronic address: l.wei@ucl.ac.uk.
Publisher: Elsevier Science Ltd Country of Publication: England NLM ID: 9005373 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1879-0852 (Electronic) Linking ISSN: 09598049 NLM ISO Abbreviation: Eur J Cancer Subsets: MEDLINE
검색 결과 제한하기
제한된 항목
[검색어] Nicum, S.
발행연도 제한
-
학술DB(Database Provider)
저널명(출판물, Title)
출판사(Publisher)
자료유형(Source Type)
주제어
언어